Aquatic Capital Management LLC

Position in GILD — Gilead Sciences, Inc.

CIK 1803916 CHICAGO, IL

Position in GILD

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$3,720,207

-$2,868,231 QoQ

Shares Held

29,446

-37.7% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

0.13%

of 13F equity value

Holder Rank

#654

of 2,266 holders

Holding Since

Dec 2021

6 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Aquatic Capital Management LLC holds $26,569,563 across 5 Drug Manufacturers - General names. GILD ranks #3 (14.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	AZN	Astrazeneca PLC	68,181	$12,928,481
2	AMGN	Amgen Inc	18,128	$6,564,511
3	GILD	Gilead Sciences, Inc. This page	29,446	$3,720,207
4	GSK	GSK plc	43,060	$2,257,205
5	BMY	Bristol Myers Squibb Co	19,076	$1,099,159

6 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$3,720,207	29,446	-37.7%	Shares	Sole	2026-08-14
2026-03-31	$6,588,438	47,273	+23.4%	Shares	Sole	2026-05-15
2025-03-31	$4,291,851	38,303	-83.2%	Shares	Sole	2025-05-15
2024-03-31	$16,693,675	227,900	+394.4%	Shares	Sole	2024-05-15
2023-09-30	$3,454,734	46,100	+1489.7%	Shares	Sole	2023-11-14
2021-12-31	$210,569	2,900	—	Shares	Sole	2022-02-14
No filing history on record for this holder in this stock.